Literature DB >> 2383262

Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

A Miyata1, L Jiang, R D Dahl, C Kitada, K Kubo, M Fujino, N Minamino, A Arimura.   

Abstract

A novel neuropeptide with 38 residues (PACAP38) was isolated from ovine hypothalamic tissues using the pituitary adenylate cyclase activation in rat pituitary cell cultures as a parameter of the biological activity (Miyata et al, Biochem. Biophys. Res. Commun. 164, 567-574, 1989). From the side fractions obtained during the purification of PACAP38, a shorter form peptide with 27 residues corresponding to the N-terminal 27 amino acids of PACAP38 and amidated C-terminus was isolated and named as PACAP27. Synthetic PACAP27 showed a biological activity of adenylate cyclase stimulation comparable to PACAP38. Moreover PACAP27 which shows a considerable homology with vasoactive intestinal polypeptide (VIP) demonstrated a similar vasodepressor activity as VIP, but the adenylate cyclase stimulating activity was about 1000 times greater than VIP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383262     DOI: 10.1016/0006-291x(90)92140-u

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  147 in total

1.  Alternative splicing of the pituitary adenylate cyclase-activating polypetide (PACAP) receptor contributes to function of PACAP-27.

Authors:  Mina Ushiyama; Ryuji Ikeda; Morikatsu Yoshida; Kenji Mori; Kenji Kangawa; Hideki Sugawara; Kazuhiko Inoue; Katsushi Yamada; Atsuro Miyata
Journal:  J Mol Neurosci       Date:  2010-05-15       Impact factor: 3.444

2.  Pituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line.

Authors:  H Oka; L Jin; E Kulig; B W Scheithauer; R V Lloyd
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

5.  Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.

Authors:  P Gressens; J M Hill; B Paindaveine; I Gozes; M Fridkin; D E Brenneman
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Glial expression of the proenkephalin gene in slice cultures of the subventricular zone.

Authors:  L Just; C Olenik; D K Meyer
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

7.  Pituitary adenylate cyclase-activating polypeptide: Postnatal development in multiple brain stem respiratory-related nuclei in the rat.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  Respir Physiol Neurobiol       Date:  2018-10-22       Impact factor: 1.931

8.  Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.

Authors:  Sebastian Bardosi; Attila Bardosi; Zsuzsanna Nagy; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

9.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Comparison of expression and proliferative effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors on human astrocytoma cell lines.

Authors:  Tomoya Nakamachi; Kouichi Sugiyama; Jun Watanabe; Nori Imai; Nobuyuki Kagami; Motohide Hori; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2014-08-06       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.